All CUTX-101 articles
-
NewsSentynl secures US-first approval for rare Menkes disease
The US biopharma company can now offer a new treatment option for eligible paediatric patients with the genetic disease.
The US biopharma company can now offer a new treatment option for eligible paediatric patients with the genetic disease.